Intercept Pharmaceuticals (ICPT) PT Lowered to $106 at Citi
Tweet Send to a Friend
Citi analyst Joel Beatty lowered the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $106.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
